FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037247287> ?p ?o ?g. }

• W2037247287 endingPage "516" @default.
• W2037247287 startingPage "510" @default.
• W2037247287 abstract "Recientemente se ha comunicado el éxito del tratamiento con propranolol para hemangiomas infantiles (HI) graves. Existen escasas series publicadas con reducido número de pacientes. El objetivo del presente estudio fue conocer la efectividad y seguridad de propranolol oral para HI graves. Estudio observacional y descriptivo de una serie de niños con HI graves en fase proliferativa, o en fase involutiva si presentaban importante deformidad residual, que acudieron a la Unidad de Dermatología Pediátrica de nuestro hospital desde junio de 2008 hasta diciembre de 2009 y fueron tratados con propranolol oral (dosis de 2 mg/kg/día). Fueron seguidos hasta septiembre de 2010. Se analizaron las características epidemiológicas, la respuesta al mes, 3, 6, 9, 12 y 18 meses y se registraron los efectos adversos. Se trataron 36 HI en 28 pacientes. El tratamiento con propranolol fue efectivo en todos los casos, con respuesta completa o buena en el 88,2% de los casos a los 6 meses de tratamiento. El efecto fue evidente en las primeras horas tras instaurar el tratamiento, siendo útil tanto en fase proliferativa como involutiva. En HI ulcerados el tiempo medio de cicatrización fue de 61 días. Los efectos adversos fueron leves y autolimitados. Sólo dos pacientes discontinuaron el tratamiento por hipotensión. El propanol oral induce una mejoría rápida y mantenida en la gran mayoría de los HI, acortando considerablemente su evolución natural y con escasos efectos secundarios. En HI ulcerados no observamos una reducción significativa de la sintomatología o tiempo de cicatrización. Recent reports have described the successful use of propranolol to treat severe hemangiomas of infancy. The few case series that have been reported, however, have included only a small number of patients. The aim of this study was to describe the results of oral propranolol treatment for severe hemangiomas of infancy in terms of treatment outcome and the occurrence of adverse events. A descriptive, observational study was undertaken in a series of children with severe hemangiomas of infancy seen in the pediatric dermatology unit at Hospital Universitario Virgen del Rocío in Seville, Spain between July 2008 and December 2009. Patients were included if they had hemangiomas in the proliferative phase or involuting lesions with substantial residual deformity. All children were treated with oral propranolol (2 mg/kg/d) and followed until September 2010. Epidemiologic characteristics were analyzed along with treatment response at 3, 6, 9, 12, and 18 months; adverse events were also recorded at those times. Thirty-six hemangiomas were treated in 28 patients. Propranolol treatment was effective in all cases, with a good or complete response in 88.2% at 6 months. Effects were apparent within a few hours of treatment, which was effective in both growing and involuting hemangiomas. In ulcerated hemangiomas, the mean healing time was 61 days. Adverse events were mild and self-limiting. Only 2 patients discontinued treatment due to hypotension. In the majority of cases, oral propranolol produced rapid and sustained improvements in hemangiomas of infancy and shortened the natural course of the disease with few side effects. However, no significant reductions in symptoms or healing time were observed in ulcerated hemangiomas." @default.
• W2037247287 created "2016-06-24" @default.
• W2037247287 creator A5006514339 @default.
• W2037247287 creator A5024278971 @default.
• W2037247287 creator A5071369693 @default.
• W2037247287 creator A5079830079 @default.
• W2037247287 creator A5091132589 @default.
• W2037247287 creator A5091763831 @default.
• W2037247287 date "2011-09-01" @default.
• W2037247287 modified "2023-10-18" @default.
• W2037247287 title "Tratamiento con propranolol oral para hemangiomas infantiles graves: serie de 28 pacientes" @default.
• W2037247287 cites W1539254583 @default.
• W2037247287 cites W1910665068 @default.
• W2037247287 cites W1963910752 @default.
• W2037247287 cites W1990464693 @default.
• W2037247287 cites W1991951767 @default.
• W2037247287 cites W1997269559 @default.
• W2037247287 cites W1999851192 @default.
• W2037247287 cites W2000081320 @default.
• W2037247287 cites W2006718103 @default.
• W2037247287 cites W2009970014 @default.
• W2037247287 cites W2010974371 @default.
• W2037247287 cites W2024835966 @default.
• W2037247287 cites W2031469858 @default.
• W2037247287 cites W2033318447 @default.
• W2037247287 cites W2039529957 @default.
• W2037247287 cites W2048633013 @default.
• W2037247287 cites W2051372744 @default.
• W2037247287 cites W2055089681 @default.
• W2037247287 cites W2067076362 @default.
• W2037247287 cites W2071771837 @default.
• W2037247287 cites W2101325544 @default.
• W2037247287 cites W2107603505 @default.
• W2037247287 cites W2113398862 @default.
• W2037247287 cites W2116925825 @default.
• W2037247287 cites W2116932780 @default.
• W2037247287 cites W2121231063 @default.
• W2037247287 cites W2154845597 @default.
• W2037247287 cites W2156095296 @default.
• W2037247287 cites W2340893063 @default.
• W2037247287 doi "https://doi.org/10.1016/j.ad.2011.02.009" @default.
• W2037247287 hasPublicationYear "2011" @default.
• W2037247287 type Work @default.
• W2037247287 sameAs 2037247287 @default.
• W2037247287 citedByCount "22" @default.
• W2037247287 countsByYear W20372472872012 @default.
• W2037247287 countsByYear W20372472872013 @default.
• W2037247287 countsByYear W20372472872014 @default.
• W2037247287 countsByYear W20372472872015 @default.
• W2037247287 countsByYear W20372472872016 @default.
• W2037247287 countsByYear W20372472872017 @default.
• W2037247287 countsByYear W20372472872018 @default.
• W2037247287 countsByYear W20372472872021 @default.
• W2037247287 crossrefType "journal-article" @default.
• W2037247287 hasAuthorship W2037247287A5006514339 @default.
• W2037247287 hasAuthorship W2037247287A5024278971 @default.
• W2037247287 hasAuthorship W2037247287A5071369693 @default.
• W2037247287 hasAuthorship W2037247287A5079830079 @default.
• W2037247287 hasAuthorship W2037247287A5091132589 @default.
• W2037247287 hasAuthorship W2037247287A5091763831 @default.
• W2037247287 hasConcept C126322002 @default.
• W2037247287 hasConcept C142362112 @default.
• W2037247287 hasConcept C15708023 @default.
• W2037247287 hasConcept C2778151854 @default.
• W2037247287 hasConcept C71924100 @default.
• W2037247287 hasConceptScore W2037247287C126322002 @default.
• W2037247287 hasConceptScore W2037247287C142362112 @default.
• W2037247287 hasConceptScore W2037247287C15708023 @default.
• W2037247287 hasConceptScore W2037247287C2778151854 @default.
• W2037247287 hasConceptScore W2037247287C71924100 @default.
• W2037247287 hasIssue "7" @default.
• W2037247287 hasLocation W20372472871 @default.
• W2037247287 hasOpenAccess W2037247287 @default.
• W2037247287 hasPrimaryLocation W20372472871 @default.
• W2037247287 hasRelatedWork W1557907936 @default.
• W2037247287 hasRelatedWork W2022948112 @default.
• W2037247287 hasRelatedWork W2111865594 @default.
• W2037247287 hasRelatedWork W2248387313 @default.
• W2037247287 hasRelatedWork W2417955275 @default.
• W2037247287 hasRelatedWork W2748952813 @default.
• W2037247287 hasRelatedWork W2899084033 @default.
• W2037247287 hasRelatedWork W3030044343 @default.
• W2037247287 hasRelatedWork W3203105381 @default.
• W2037247287 hasRelatedWork W4247680379 @default.
• W2037247287 hasVolume "102" @default.
• W2037247287 isParatext "false" @default.
• W2037247287 isRetracted "false" @default.
• W2037247287 magId "2037247287" @default.
• W2037247287 workType "article" @default.